More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic Leukemia (B-ALL) next year in Spain, according to the latest projections from the Spanish network of cancer ...
Oct 21, 2024
0
15
Researchers at Children's Hospital of Philadelphia (CHOP) revealed for the first time that children, adolescents and young adults may experience very rare neurological issues of paraparesis and quadriparesis following chimeric ...
Oct 8, 2024
0
18
Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).
Sep 24, 2024
0
30
Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell ...
Aug 12, 2024
0
41
Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates of over 85% compared to 50%–75% in adults.
Aug 6, 2024
0
31
Researchers from the University of South Australia have developed a new technique to significantly enhance a powerful treatment for leukemia and other blood cancers.
Jul 19, 2024
0
49
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukemia—in a humanized animal model. The results mark a key step in the realization of ePCs as therapies ...
Jul 2, 2024
0
52
Valrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death & Disease describes the repurposing of this molecule ...
Jun 6, 2024
0
37
Researchers from Karolinska Institutet have, in collaboration with the University of Eastern Finland and Lund University, published a study in Genome Biology demonstrating that targeting cell cycle and cell fate regulatory ...
Jun 3, 2024
0
31
Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
May 31, 2024
0
48
